Baidu
map

阿司匹林那么牛,不良反应您知道吗?

2017-01-11 陈瑞锋医生 心健康

阿司匹林肠溶片几乎是所有心脑血管疾病病人一级预防及二级预防的基石,作为常用药物之一,其在心内科以绝对的优势稳居药物榜,今天我们再次走进阿司匹林,了解一下这么牛的阿司匹林肠溶片,口服后会有那些不良反应呢?1.消化道症状阿司匹林肠溶片做为口服用药,经消化道代谢过程中,其肠溶片外的包衣溶解快慢决定了其在体内代谢的位置。如果肠溶衣代谢过快,药物还没有到肠道,而仍在胃内,其对胃粘膜的损害为直接性的,有相关报


阿司匹林肠溶片几乎是所有心脑血管疾病病人一级预防及二级预防的基石,作为常用药物之一,其在心内科以绝对的优势稳居药物榜,今天我们再次走进阿司匹林,了解一下这么牛的阿司匹林肠溶片,口服后会有那些不良反应呢?

1.消化道症状

阿司匹林肠溶片做为口服用药,经消化道代谢过程中,其肠溶片外的包衣溶解快慢决定了其在体内代谢的位置。如果肠溶衣代谢过快,药物还没有到肠道,而仍在胃内,其对胃粘膜的损害为直接性的,有相关报道显示,口服阿司匹林肠溶片的患者中,有消化道症状的病人可达15%,而这些症状多表现为胃部疼痛、反酸、烧心或者胃胀等不适。

如患者有胃溃疡,需慎用阿司匹林,若必须服用时,应同时服用胃黏膜保护剂,或改用氯吡格雷口服;此外须密切监测有无消化道出血情况。

2.皮下出血或脏器出血

阿司匹林肠溶片是通过抑制血小板的作用从而起到预防血栓的作用,而抑制血小板功能,必将会导致出血几率发生的风险增高。而出血则表现为各式各样,尤其以皮下出血较为常见,其可表现为皮下淤青、皮下出血点等等,而消化道出血则为脏器出血中的常见部位,其次可能为牙龈出血、脑出血、鼻部出血、咯血等等其他部位出血。

3.过敏反应

过敏反应本身是一种变态反应,是指已免疫的机体在再次接受相同物质的刺激时所发生的反应。过敏体质的人对花粉、粉尘等等常见物的过敏我们早已司空见惯。所以,对阿司匹林本身的过敏,或者对药物制作过程中相关配料的过敏也就不足为奇了。

4.阿司匹林哮喘

阿司匹林哮喘之所以单独列出,还是因为其同过敏有区别。所谓的阿司匹林哮喘,是无论既往是否有哮喘病史,当口服阿司匹林后数分钟内或数小时内出现诱发的哮喘发作,称阿司匹林哮喘。其主要机制为此类药抑制环氧酶,使PG合成受阻,但不影响脂氧酶,致使引起支气管收缩的白三烯增多而诱发哮喘。

5.溶血和溶血性贫血

溶血及溶血性贫血较为少见,多见于严重葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症患者,临床较少碰到。而碰到隐匿性的消化道出血所致的贫血则较为常见。

6.肝肾功能损伤和其他。

阿司匹林肠溶片很少报道有肝肾功能损害,而阿司匹林肠溶片导致出血后或者贫血后的肝肾功能损害可能相对多见,而其所致的其他不良反应,比如药物过量后的头晕、眩晕、耳鸣、出汗、恶心和呕吐、头痛等则更为少见,多数均可在减少剂量或者停药后得以控制。

所以亲,阿司匹林再牛,用药也需谨慎。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1840510, encodeId=41c81840510e6, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Wed Dec 20 07:15:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171473, encodeId=e6441e14730e, content=挺好的文章,常见的药,很有用谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad01994393, createdName=溜溜梅不酸, createdTime=Fri Jan 20 01:20:57 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170536, encodeId=80c41e0536be, content=再好也不能当饭吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jan 15 14:23:15 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169905, encodeId=69031699059d, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Jan 12 19:53:00 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169726, encodeId=a640169e2669, content=副作用不可避免, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Thu Jan 12 02:39:22 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169719, encodeId=fd1a169e196c, content=很有必要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Wed Jan 11 23:51:54 CST 2017, time=2017-01-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1840510, encodeId=41c81840510e6, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Wed Dec 20 07:15:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171473, encodeId=e6441e14730e, content=挺好的文章,常见的药,很有用谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad01994393, createdName=溜溜梅不酸, createdTime=Fri Jan 20 01:20:57 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170536, encodeId=80c41e0536be, content=再好也不能当饭吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jan 15 14:23:15 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169905, encodeId=69031699059d, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Jan 12 19:53:00 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169726, encodeId=a640169e2669, content=副作用不可避免, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Thu Jan 12 02:39:22 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169719, encodeId=fd1a169e196c, content=很有必要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Wed Jan 11 23:51:54 CST 2017, time=2017-01-11, status=1, ipAttribution=)]
    2017-01-20 溜溜梅不酸

    挺好的文章,常见的药,很有用谢谢了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1840510, encodeId=41c81840510e6, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Wed Dec 20 07:15:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171473, encodeId=e6441e14730e, content=挺好的文章,常见的药,很有用谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad01994393, createdName=溜溜梅不酸, createdTime=Fri Jan 20 01:20:57 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170536, encodeId=80c41e0536be, content=再好也不能当饭吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jan 15 14:23:15 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169905, encodeId=69031699059d, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Jan 12 19:53:00 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169726, encodeId=a640169e2669, content=副作用不可避免, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Thu Jan 12 02:39:22 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169719, encodeId=fd1a169e196c, content=很有必要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Wed Jan 11 23:51:54 CST 2017, time=2017-01-11, status=1, ipAttribution=)]
    2017-01-15 Gsurgeon

    再好也不能当饭吃

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1840510, encodeId=41c81840510e6, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Wed Dec 20 07:15:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171473, encodeId=e6441e14730e, content=挺好的文章,常见的药,很有用谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad01994393, createdName=溜溜梅不酸, createdTime=Fri Jan 20 01:20:57 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170536, encodeId=80c41e0536be, content=再好也不能当饭吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jan 15 14:23:15 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169905, encodeId=69031699059d, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Jan 12 19:53:00 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169726, encodeId=a640169e2669, content=副作用不可避免, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Thu Jan 12 02:39:22 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169719, encodeId=fd1a169e196c, content=很有必要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Wed Jan 11 23:51:54 CST 2017, time=2017-01-11, status=1, ipAttribution=)]
    2017-01-12 xiaotaiyang1

    了解一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1840510, encodeId=41c81840510e6, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Wed Dec 20 07:15:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171473, encodeId=e6441e14730e, content=挺好的文章,常见的药,很有用谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad01994393, createdName=溜溜梅不酸, createdTime=Fri Jan 20 01:20:57 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170536, encodeId=80c41e0536be, content=再好也不能当饭吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jan 15 14:23:15 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169905, encodeId=69031699059d, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Jan 12 19:53:00 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169726, encodeId=a640169e2669, content=副作用不可避免, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Thu Jan 12 02:39:22 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169719, encodeId=fd1a169e196c, content=很有必要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Wed Jan 11 23:51:54 CST 2017, time=2017-01-11, status=1, ipAttribution=)]
    2017-01-12 187清风

    副作用不可避免

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1840510, encodeId=41c81840510e6, content=<a href='/topic/show?id=9401204912f' target=_blank style='color:#2F92EE;'>#不良反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20491, encryptionId=9401204912f, topicName=不良反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Wed Dec 20 07:15:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171473, encodeId=e6441e14730e, content=挺好的文章,常见的药,很有用谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad01994393, createdName=溜溜梅不酸, createdTime=Fri Jan 20 01:20:57 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170536, encodeId=80c41e0536be, content=再好也不能当饭吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a6a1604604, createdName=Gsurgeon, createdTime=Sun Jan 15 14:23:15 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169905, encodeId=69031699059d, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Jan 12 19:53:00 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169726, encodeId=a640169e2669, content=副作用不可避免, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Thu Jan 12 02:39:22 CST 2017, time=2017-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169719, encodeId=fd1a169e196c, content=很有必要学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d782007349, createdName=1e1e0321m25(暂无匿称), createdTime=Wed Jan 11 23:51:54 CST 2017, time=2017-01-11, status=1, ipAttribution=)]
    2017-01-11 1e1e0321m25(暂无匿称)

    很有必要学习

    0

相关资讯

2016年终盘点:“神药”阿司匹林是否真的能够抵抗癌症?

医药史上的三大经典药物包括阿司匹林、青霉素和安定,其中药物阿司匹林在穿越了百年的风雨沉浮之后,终于焕发出了新的光彩。美国预防服务工作组在发表的最新指南中指出,阿司匹林能够作为心血管疾病和结直肠癌的一级预防药物。关于阿司匹林与癌症的关系,众说纷纭,现在这个问题终于有定论了,这项最新指南正式将阿司匹林作为预防结直肠癌的一级预防药物了。那么阿司匹林到底是否能够预防癌症,或者说是帮助机体抵御癌症呢?请

小剂量阿司匹林为何能降低癌症的发生风险?

世界范围内癌症是造成死亡的首要病因,据估计未来几年癌症的发病率仍会上升。癌症的预防策略包括选择健康的生活方式,癌症高风险人群定期进行筛查等。近日,来自俄勒冈健康与科学大学(OHSU)与俄勒冈州立大学(OSU)的一项新的研究表明,小剂量阿司匹林有助于防止癌细胞的形成,并解释了这背后的机制,该研究结果已发表于AJP-Cell Physiology。研究显示,除了凝血外,血小板还可增加机体某些蛋白的水平

JNCI:长期服用阿司匹林,会增加某类癌症的死亡风险

导读 常常听说阿司匹林能降低癌症风险,但最近,研究人员发现,长期服用阿司匹林等非甾体类抗炎药与I型子宫内膜癌的死亡风险增加有关。研究人员认为,虽然这些数据有趣,但仍需进一步研究。

CEBP:每日服用低剂量阿司匹林可能会降低胰腺癌风险

一项新出炉的研究显示,每天服用低剂量的阿司匹林可能会降低患胰腺癌的风险。据合众国际社报道,该研究论文主要作者、耶鲁公共卫生学院流行病学教授里施(Harvey Risch)博士表示,来自中国的这项研究虽然并未证明其中的因果关系,然而一些明显证据表明,服用阿司匹林不仅可降低患心血管病或结直肠癌的风险,也有可能会降低人们患胰腺癌的风险。据美国癌症协会统计,今年约有5.3万美国人将被诊断为胰腺癌,每年约4

每日服用低剂量阿司匹林可能会降低胰腺癌风险

一项新出炉的研究显示,每天服用低剂量的阿司匹林可能会降低患胰腺癌的风险。据合众国际社报道,该研究论文主要作者、耶鲁公共卫生学院流行病学教授里施(Harvey Risch)博士表示,来自中国的这项研究虽然并未证明其中的因果关系,然而一些明显证据表明,服用阿司匹林不仅可降低患心血管病或结直肠癌的风险,也有可能会降低人们患胰腺癌的风险。据美国癌症协会统计,今年约有5.3万美国人将被诊断为胰腺癌,每年约4

PLOS ONE:全新证据!每天服用阿司匹林降低心脏病风险、预防癌症、延长寿命

导读 每天服用低剂量的阿司匹林究竟能否带来健康益处在今年引起了争议。近日,发表在PLOS ONE杂志上的一项研究给出了新的支持证据。研究表示,每天服用低剂量的阿司匹林能够降低心脏病发作的风险,预防某些癌症和癌症相关死亡并延长寿命。

Baidu
map
Baidu
map
Baidu
map